Retail investors booked their quota 7.6 times, while the Non-Institutional Investors’ (NIIs) category led the demand for the IPO with a subscription of 14.05 times. The Qualified Institutional Buyers (QIBs) booked the portion reserved for them 1.62 times.
Gaudium IVF IPO, which opened for bidding on February 20, comprised a fresh issue of 1.13 crore shares, aggregating to ₹90 crore, and an offer-for-sale (OFS) portion of nearly 95 lakh shares, worth ₹75 crore. The price band for the Gaudium IVF was set at ₹75 to ₹79.As per the company’s draft prospectus, Gaudium IVF aims to use the IPO proceeds for capital expenditure towards the establishment of new IVF centres, repayment or prepayment of outstanding loans and general corporate purposes.
The Gaudium IVF IPO bidders can check the share allotment status on the websites of the NSE, BSE and the issue registrar, Bigshare Services Pvt. Ltd.
Steps to check Gaudium IVF and Women Health IPO allotment status on the BSE:
Click on the IPO allotment page here.
On Issue Type, click on ‘Equity’.
Under the Issue Name dropdown, select ‘Gaudium IVF & Women Health Ltd’.
Fill in your IPO application number or PAN to proceed.
Complete the Captcha verification.
Finally, click on ‘Search’ to view your share allotment detailsHow to check Gaudium IVF IPO share allotment on the NSE:
Click on the IPO allotment page on NSE here.
Select the option ‘Equity & SME IPO bid details’.
Click on ‘GAUDIUMIVF’ from the ‘Select Symbol’ dropdown list.
Enter your application number and PAN to proceed.
Once entered, click on the ‘Submit’ button.
Steps to check IPO allotment status on Bigshare Services:
Go to the IPO allotment status page on the Bigshare Services website here.
Select any one of the three server options.
From the ‘Select Company’ dropdown list, choose ‘Gaudium IVF and Women Health’.
Under ‘Select Selection Type’, choose any of these options: Application number, Beneficiary ID, PAN Number.
Enter details and complete Captcha verification.
Click on ‘Search’ to view your allotment status.
Successful bidders receive shares of Gaudium IVF in their Demat accounts on Thursday, February 26, while the refunds for unsuccessful applicants will also be issued on February 25. The company’s shares are set to debut on the NSE and BSE on Friday, February 27.
Incorporated in March 2015, Gaudium IVF and Women Health provides in vitro fertilization (IVF) treatment across India. It operates fertility treatment centres across 30 locations in multiple cities, including Delhi, Mumbai and Bengaluru.
